156 related articles for article (PubMed ID: 36376218)
1. The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients.
Vietzen H; Jaksch P; Puchhammer-Stöckl E
J Heart Lung Transplant; 2023 Mar; 42(3):305-314. PubMed ID: 36376218
[TBL] [Abstract][Full Text] [Related]
2. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis.
Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E
mBio; 2021 Mar; 12(2):. PubMed ID: 33727352
[TBL] [Abstract][Full Text] [Related]
3. Association between chronic lung allograft dysfunction and human Cytomegalovirus UL40 peptide variants in lung-transplant recipients.
Vietzen H; Hartenberger S; Jaksch P; Puchhammer-Stöckl E
J Heart Lung Transplant; 2021 Sep; 40(9):900-904. PubMed ID: 34183227
[TBL] [Abstract][Full Text] [Related]
4. Late Development of FcεRγ
Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
Front Immunol; 2018; 9():1050. PubMed ID: 29868012
[TBL] [Abstract][Full Text] [Related]
5. Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction.
Rousselière A; Delbos L; Foureau A; Reynaud-Gaubert M; Roux A; Demant X; Le Pavec J; Kessler R; Mornex JF; Messika J; Falque L; Le Borgne A; Boussaud V; Tissot A; Hombourger S; Bressollette-Bodin C; Charreau B
Front Immunol; 2023; 14():1143875. PubMed ID: 37187736
[TBL] [Abstract][Full Text] [Related]
6. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
Holder KA; Lajoie J; Grant MD
Front Immunol; 2018; 9():2494. PubMed ID: 30483249
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
Comeau EM; Holder KA; Fudge NJ; Grant MD
Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56
Bailly E; Macedo C; Ossart J; Louis K; Gu X; Ramaswami B; Bentlejewski C; Zeevi A; Randhawa P; Lefaucheur C; Metes D
Kidney Int; 2023 Oct; 104(4):707-723. PubMed ID: 37220805
[TBL] [Abstract][Full Text] [Related]
9. Deletion of the Natural Killer Cell Receptor NKG2C Encoding
Vietzen H; Döhler B; Tran TH; Süsal C; Halloran PF; Eskandary F; Herz CT; Mayer KA; Kozakowski N; Wahrmann M; Ely S; Haindl S; Puchhammer-Stöckl E; Böhmig GA
Front Immunol; 2022; 13():829228. PubMed ID: 35401541
[TBL] [Abstract][Full Text] [Related]
10. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.
Gumá M; Budt M; Sáez A; Brckalo T; Hengel H; Angulo A; López-Botet M
Blood; 2006 May; 107(9):3624-31. PubMed ID: 16384928
[TBL] [Abstract][Full Text] [Related]
11. Do variations in the HLA-E ligand encoded by UL40 distinguish individuals susceptible to HCMV disease?
Waters S; Allcock RJN; Lee S; Downing J; Ariyanto I; Leary S; Munyard K; Irish A; Price P
Hum Immunol; 2023 Feb; 84(2):75-79. PubMed ID: 36456304
[TBL] [Abstract][Full Text] [Related]
12. Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance.
Shirane M; Yawata N; Motooka D; Shibata K; Khor SS; Omae Y; Kaburaki T; Yanai R; Mashimo H; Yamana S; Ito T; Hayashida A; Mori Y; Numata A; Murakami Y; Fujiwara K; Ohguro N; Hosogai M; Akiyama M; Hasegawa E; Paley M; Takeda A; Maenaka K; Akashi K; Yokoyama WM; Tokunaga K; Yawata M; Sonoda KH
Front Immunol; 2022; 13():1008220. PubMed ID: 36341392
[TBL] [Abstract][Full Text] [Related]
13. Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells.
Hammer Q; Rückert T; Borst EM; Dunst J; Haubner A; Durek P; Heinrich F; Gasparoni G; Babic M; Tomic A; Pietra G; Nienen M; Blau IW; Hofmann J; Na IK; Prinz I; Koenecke C; Hemmati P; Babel N; Arnold R; Walter J; Thurley K; Mashreghi MF; Messerle M; Romagnani C
Nat Immunol; 2018 May; 19(5):453-463. PubMed ID: 29632329
[TBL] [Abstract][Full Text] [Related]
14. Functional and clinical consequences of changes to natural killer cell phenotypes driven by chronic cytomegalovirus infections.
Lee S; Doualeh M; Affandi JS; Makwana N; Irish A; Price P
J Med Virol; 2019 Jun; 91(6):1120-1127. PubMed ID: 30636352
[TBL] [Abstract][Full Text] [Related]
15. FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant.
Paul P; Pedini P; Lyonnet L; Di Cristofaro J; Loundou A; Pelardy M; Basire A; Dignat-George F; Chiaroni J; Thomas P; Reynaud-Gaubert M; Picard C
Front Immunol; 2019; 10():1208. PubMed ID: 31249568
[TBL] [Abstract][Full Text] [Related]
16. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
[TBL] [Abstract][Full Text] [Related]
17. NK cells generate memory-type responses to human cytomegalovirus-infected fibroblasts.
Newhook N; Fudge N; Grant M
Eur J Immunol; 2017 Jun; 47(6):1032-1039. PubMed ID: 28475279
[TBL] [Abstract][Full Text] [Related]
18. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.
Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A
Front Immunol; 2019; 10():687. PubMed ID: 31001281
[TBL] [Abstract][Full Text] [Related]
19. Human Cytomegalovirus (HCMV)-Specific Antibody Response and Development of Antibody-Dependent Cellular Cytotoxicity Against HCMV After Lung Transplantation.
Vietzen H; Görzer I; Honsig C; Jaksch P; Puchhammer-Stöckl E
J Infect Dis; 2020 Jul; 222(3):417-427. PubMed ID: 32157310
[TBL] [Abstract][Full Text] [Related]
20. Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.
Giménez E; Solano C; Amat P; de la Cámara R; Nieto J; López J; Garcia-Noblejas A; Navarro D
J Med Virol; 2015 Sep; 87(9):1601-7. PubMed ID: 25802229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
